There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

Wave Life Sciences has lost GSK as the partner for its RNA-editing drug for alpha-1 antitrypsin deficiency (AATD), just over ...

The UK government has set aside a £10 million (nearly $14 million) financial support package to help support families with ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Lisa Sims, executive director of learning strategy & ...

ICH E6 (R3) introduces a dedicated section on data governance, reflecting the increasing complexity of data sources and systems used in modern trials. Sponsors are expected to maintain oversight of ...

Novo Nordisk is considering additional regulatory filings for CagriSema – already submitted in the US for obesity – after the drug outperformed Ozempic in a head-to-head diabetes study.

AstraZeneca's new formulation of systemic lupus erythematosus (SLE) therapy Saphnelo has been turned down by the FDA, despite getting the go-ahead in Europe a few weeks ago.

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is ...

Joenja is a sizeable contributor to Pharming's revenues, accounting for €38 million ($45 million) of its total sales of €70 ...

Both products can be used in the UK to provide protection against RSV disease in certain settings. Abrysvo was cleared for ...

Venglustat is designed to reduce the toxic build-up, and the new trial showed that a daily dose of the drug achieved ...

Eli Lilly has revealed the fourth new manufacturing site in its $27 billion capital investment spree in the US – a $3.5 ...